L-carnitine reduces hospital admissions in patients with hepatic encephalopathy Joji Tani a Asahiro Morishita a Teppei Sakamoto a Kei Takuma a Mai Nakahara a Koji Fujita a Kyoko Oura a Tomoko Tadokoro a Shima Mimura a Takako Nomura a Hirohito Yoneyama a Hideki Kobara a Takashi Himoto b Tsutomu Masaki a Aim The aim of this study was to determine whether oral L-carnitine administration reduces the blood ammonia concentration and number of hospital admissions for hepatic encephalopathy in patients with advanced cirrhosis

Full AI Image Prompt: Create a clean regulatory infographic titled GHK-Cu Regulatory Context Map. Show a horizontal map with four labeled blocks: Cosmetic context, Non-injectable compounding review, Injectable safety concern, and Approved drug labeling. Include a small callout that says Product category affects evidence and safety interpretation. Use document-style icons, simple arrows, and a professional clinical design with white background, gray, blue, and copper accents
PMID: 11437870 | doi:10.1046/j.1365-2346.2001.00876.x Graf MV et al
Till, A., Lakhani, R., Burnett, S